NDA 090022 describes ALENDRONATE SODIUM, which is a drug marketed by
Hikma,
Novitium Pharma,
Apotex,
Aurobindo Pharma,
Chartwell Rx,
Cipla,
Hangzhou Binjiang,
Impax Labs Inc,
Jubilant Cadista,
Mylan,
Rising,
Sun Pharm,
Teva Pharms, and
Watson Labs, and is included in fifteen NDAs. It is available from
eighteen suppliers. Additional details are available on the
ALENDRONATE SODIUM profile page.
The generic ingredient in ALENDRONATE SODIUM is
alendronate sodium. There are twenty-five
drug master file entries for this compound. Twenty-one
suppliers are listed for this compound. Additional details are available on the
alendronate sodium profile page.